
|Videos|October 23, 2025 (Updated: October 23, 2025)
Innovations in Sample Preparation For Oligonucleotide Analysis
The panel discuss the innovations in sample preparation that are being developed for oligonucleotide analysis.
Advertisement
Episodes in this series

The field of oligonucleotide analysis has recently witnessed developments in the realm of sample preparation. As more kit-based solutions enter the market, researchers are seeking faster, more consistent, and automation-friendly methods. This shift raises an important question: Are we seeing a turning point where solid phase extraction (SPE) overtakes traditional liquid-liquid extraction (LLE)? In the video above, the panel explore current innovations, market trends, and their perspectives on trends shaping the future of oligonucleotide sample preparation.
Advertisement
Related to this article

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.

Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.

Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.

Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.

Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
2
LCGC Blog: Building a Career Series That Goes Beyond the Surface
3
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
4
Testing Plastic Packaging for PFAS Without SPE: A Fast, Cost-Effective Direct Shoot LC-MS/MS Method on the QSight® 500 System That Meets Regulatory Requirements
5








